Oral HRT

Oral hormone therapy is the original and still the most familiar form of HRT. When the Women's Health Initiative (WHI) made headlines in 2002 and caused a generation of women to stop taking hormones, the hormones in that trial were oral: conjugated equine estrogens and medroxyprogesterone acetate, the combination known as Prempro. Much of what women and doctors learned to fear about HRT came from oral formulations. And much of what modern menopause medicine has learned in the 20+ years since is that the delivery method matters - a lot.

This article walks through where oral HRT still belongs in modern menopause care, where transdermal options have taken over, and how to think about whether a pill is right for you.

What oral HRT includes

Oral hormone therapy means any hormone taken by mouth. The main categories:

• Oral estradiol (Estrace and generics) - bioidentical estrogen in pill form
• Conjugated equine estrogens (Premarin) - the original oral HRT estrogen, derived from pregnant mare urine
• Oral micronized progesterone (Prometrium and generics) - bioidentical progesterone, typically taken at bedtime
• Medroxyprogesterone acetate (Provera) - an older synthetic progestin
• Combination products like Activella, Prempro, or Bijuva (a bioidentical combination of estradiol and progesterone in a single pill)

Each of these has a different evidence profile, and the differences matter more than most women realize.

The first-pass liver problem

Anything you swallow goes through your digestive tract and then your liver before reaching the rest of your body. For most medications, that's fine. For oral estrogen, it has specific consequences:

• Increased clotting factors. Oral estrogen stimulates the liver to produce more of the proteins involved in blood clotting, which modestly raises the risk of deep vein thrombosis, pulmonary embolism, and stroke.
• Higher SHBG (sex hormone binding globulin). This binds up free testosterone, which can worsen low-libido symptoms.
• Effects on triglycerides and inflammation markers. Oral estrogen raises triglycerides (usually a small effect but meaningful in some women) and some inflammatory markers.

Transdermal estrogen (patches, gels, creams) bypasses the liver and does not produce these effects to the same degree. This is why most current menopause guidelines recommend transdermal over oral estrogen for women with any elevated risk for blood clots.

Who should avoid or use caution with oral estrogen

Oral estrogen is generally not the right choice if you have:

• History of blood clot, pulmonary embolism, or stroke
• Clotting disorders (Factor V Leiden, protein C/S deficiency, antiphospholipid syndrome)
• Migraine with aura (though evidence is evolving)
• Active smoker over 35
• BMI over 30 (transdermal generally preferred)
• History of heart disease or high triglycerides
• Gallbladder disease (oral estrogen increases gallstone risk)

In these situations, transdermal estrogen is the safer choice, and most menopause specialists would recommend it.

When oral estrogen is a reasonable choice

For a low-risk woman who prefers pills, oral estrogen remains a legitimate option. Indications where it can make sense:

• No cardiovascular risk factors, no clotting history, no migraine with aura, BMI in normal range
• Strong preference for pill-based dosing over patches or gels
• Inability to use transdermal due to skin conditions or allergy to adhesives
• Cost considerations - generic oral estradiol is inexpensive

That said, most menopause specialists default to transdermal even for low-risk patients because the safety advantage is real and there's generally no downside to choosing the safer route from the start.

Oral micronized progesterone: the real star

If there's a clear winner in oral HRT, it's progesterone. Oral micronized progesterone (Prometrium) is the standard of care for women with a uterus who take estrogen. It's bioidentical, well-studied, and has specific advantages:

• Sleep benefits. Oral progesterone has a sedating effect that patches and creams don't match. Taken at bedtime, it often improves sleep - a major bonus for women with menopausal insomnia.
• Favorable breast safety profile. Evidence from studies like the French E3N cohort suggests micronized progesterone has a more favorable breast cancer risk profile than synthetic progestins like medroxyprogesterone.
• Works where transdermal progesterone doesn't. Progesterone creams are not reliably sufficient to protect the uterine lining. Oral Prometrium is the evidence-based standard.

For women on transdermal estrogen, oral Prometrium is typically the progesterone of choice. This "mixed" approach - transdermal estrogen plus oral progesterone - is one of the most commonly prescribed HRT regimens by menopause specialists.

Continuous versus cyclic oral HRT

Oral HRT can be given in two patterns:

• Continuous combined: estrogen and progesterone daily without a break. Typically causes no bleeding after the first 6-12 months. Standard for women clearly past menopause.
• Cyclic: estrogen daily with progesterone for 10-14 days each month. Causes a predictable monthly bleed. Sometimes used in early perimenopause when periods are still present.

Your provider will recommend one pattern based on your timeline and whether you still have a uterus.

What oral HRT can and can't do

Oral HRT effectively treats:

• Hot flashes and night sweats
• Vaginal dryness and atrophy (systemic, though local may still help)
• Mood changes related to hormone fluctuation
• Sleep disruption (especially with oral Prometrium)
• Bone density loss prevention
• Musculoskeletal aches and joint pain in some women

Oral HRT does not replace testosterone (since oral testosterone is not appropriate for most women), and for women specifically needing testosterone therapy, a separate approach is needed.

Cost and coverage

Generic oral estradiol and generic micronized progesterone are among the least expensive prescription HRT options. Generic Prometrium is typically under $20-30 per month without insurance, and oral estradiol tablets are often similar. Brand-name products and combination pills can be more expensive, but the bioidentical generics are widely available and inexpensive.

The bottom line

Oral HRT is not outdated - but the way we use it has evolved. For estrogen, transdermal delivery has largely become the preferred route, especially for women with any cardiovascular or clotting risk factors. For progesterone, oral micronized progesterone remains the clear first choice for most women on HRT.

A common, well-supported regimen today is: estradiol patch or gel plus oral Prometrium at bedtime. This combines the safety of transdermal estrogen with the sleep and safety benefits of oral bioidentical progesterone. For many women, it's the sweet spot.

If your provider has suggested oral estrogen and you're not sure why, it's worth asking whether transdermal would be a better fit for your risk profile.

This article is for educational purposes only and is not medical advice. Hormone therapy decisions should be made with a qualified healthcare provider who can evaluate your individual health history, risk factors, and symptoms. The information here is based on current clinical guidelines and published research, but medicine evolves - always consult your provider for the most current recommendations.